Dipyridamole and dilazep suppress oxygen radicals in puromycin aminonucleoside nephrosis rats

European Journal of Clinical Investigation

Volumn 28, Issue 11, 1998, Pages 877-883

  Nakamura, K ^a   Kojima, K ^a   Arai, T ^a   Shirai, M ^a   Usutani, S ^a   Akimoto, H ^a   Masaoka, H ^a   Nagase, M ^a   Yamamoto, M ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN COLLEGE OF INDUSTRIAL TECHNOLOGY   (Japan)

Author keywords

Chemiluminescence; Dilazep; Dipyridamole; Electron spin resonance; Hydroxyl radical; Puromycin aminonucleoside

Indexed keywords

CATALASE; DILAZEP; DIMETHYLTHIOUREA; DIPYRIDAMOLE; HYDROXYL RADICAL; OXYGEN RADICAL; PUROMYCIN AMINONUCLEOSIDE; SCAVENGER; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; GLOMERULUS; MALE; NEPHROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHEMILUMINESCENT MEASUREMENTS; DILAZEP; DIPYRIDAMOLE; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; FREE RADICALS; HYDROXYL RADICAL; KIDNEY GLOMERULUS; MALE; NEPHROSIS; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 0031798109     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00378.x     Document Type: Article

References (39)

1. Shah SV. The role of reactive oxygen metabolites in experimental glomerular disease. Annu Rev Physiol 1995; 57: 245-62.
2. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989; 35: 1093-106.
3. Baud L, Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol 1986; 251: F765-76.
4. Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 1991; 5: 733-42.
5. Lannigan R, Kark R, Pollak VE. The effect of a single i.v. injection of aminonucleoside of puromycin on the rat kidney. J Pathol Bacteriol 1962; 83: 357-62.
6. Kawaguchi M, Yamada M, Wada H, Okigaki T. Roles of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicology 1992; 72: 329-40.
7. Ricardo SD, Bertram JF, Ryan GB. Reactive oxygen species in puromycin aminonucleoside nephrosis: In vivo studies. Kidney Int 1994; 45: 1057-69.
8. Nakamura K, Shimomura M, Kakuta S et al. Mechanism of antiproteinuric effect of dipyridamole and dilazep in amino-nucleoside induced proteinuria of rats. Abstract from the XIIth International Congress of Nephrology. 1993: 36.
9. Beaman M, Birtwistle R, Howie AJ, Michael J, Adu D. The role of superoxide anion and hydrogen peroxide in glomerular injury induced by puromycin aminonucleoside in rats. Clin Sci 1987; 73: 329-32.
10. Thakur V, Walker PD, Shah SV. Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 1988; 34: 494-9.
11. Nagase M, Kumagi H, Honda N. Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy. Renal Physiol 1984; 7: 218-26.
12. Nagase M, Kobayashi S, Sakakibara K, Honda N. Amelioration of albuminuria induced by dilazep administration in aminonucleoside nephrosis of rats. Jpn J Nephrol 1985; 27: 385-91.
13. Shah SV, Nuam-Bedigan S. Light emission by isolated rat glomeruli in response to phorbol myristate acetate. J Lab Clin Med 1981; 98: 46-57.
14. Rise EW. Improved biuret procedure for routine determination of urinary total proteins in clinical proteinuria 1975; 21: 398-401.
15. Asada K, Takahashi M, Nagate M. Assay and inhibitors of spinach superoxide dismutase. Agr Biol Chem 1974; 38: 471-3.
16. Goldstein S, Meyerstein D, Czapski G. The Fenton reagents. Free Radic Biol Med 1993; 15: 435-45.
17. Finkelstein E, Rosen GM, Rauckman EJ. Spin trapping kinetics of the reaction of superoxide and hydroxyl radicals with nitrones. J Am Chem Soc 1980; 102: 4994-9.
18. Fantone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982; 107: 397-418.
19. Boyce NW, Holdsworth SR. Hydroxyl radical mediation of immune renal injury: abrogation of renal injury and neutrophil hydroxyl radical generation by desferrioxamine. Kidney Int 1986; 30: 813-7.
20. Boyce NW, Tipping PG, Holdsworth SR. Glomerular macrophage produce reactive oxygen species in experimental glomerulonephritis 1989; 35: 778-82.
21. Kakuta S, Nakamura K, Shimomura M et al. Role of reactive oxygen species in the development of glomerular injury. Contrib Nephrol 1993; 101: 255-62.
22. Kakuta S, Nagase M, Nakamura K et al. Role of reactive oxygen species in adriamycin induced nephrosis. Acta Med Biol 1991; 39 (Suppl.): 63-6.
23. Diamond JR, Bonventre JV, Karnovsky MJ. A role for oxygen radicals in aminonucleoside nephrosis. Kidney Int 1986; 29: 478-83.
24. Ricardo SD, Bertram JF, Ryan GB. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats. J Am Soc Nephrol 1994; 14: 1974-86.
25. Ginevri F, Gusmano R, Oleggini R et al. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis. Clin Sci 1990; 78: 283-93.
26. Kanwar YS, Rosenzeig LJ. Altered glomerular permeability as a result of focal detachment of the visceral epithelium. Kidney Int 1982; 21: 565-74.
27. Messina A, Davies DJ, Dillane PC, Ryan GB. Glomerular epithelial abnormalities associated with the onset of proteinuria in aminonucleoside nephrosis. Am J Pathol 1987; 126: 220-9.
28. Suzuki S, Sugai K, Sato H, Sakatume M, Arakawa M. Inhibition of oxygen generation by dipyridamole in human polymorphonuclear leukocytes. Eur J Pharmacol 1992; 227: 395-401.
29. Nosaka K, Takahashi T, Nishi T et al. An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity. Free Radic Biol Med 1997; 22: 597-605.
30. Ghiggeri GM, Cercignani G, Ginevri F et al. Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro. Kidney Int 1991; 40: 35-40.
31. Gwinner W, Landmesser U, Brandes R et al. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J Am Soc Nephrol 1997; 8: 1722-31.
32. Zent R, Ailenberg M, Waddel TK, Downey GP, Silverman M. Puromycin aminonucleoside inhibits mesangial cell-induced contraction of collagen gels by stimulating production of reactive oxygen species. Kidney Int 1995; 47: 811-7.
33. Johnson RJ, Lovett D, Lehrer RI, Couser WG, Klebanoff SJ. Role of oxidants and proteases in glomerular injury. Kidney Int 1994; 45: 352-9.
34. Janzen EG, Nutter DE Jr, Davies ER, Blackburn BJ, Poyer JL, McCay PB. On spin trapping hydroxyl and hydroperoxyl radicals. Can J Chem 1978; 56: 2237-42.
35. Beuttner GR, Oberley LW. Considerations in the spin trapping of superoxide and hydroxyl radical in aqueous systems using 5,5-dimethyl-1-pyrroline-1-oxide. Biochem Biophys Res Commun 1978; 83: 69-74.
36. Finkelstein E, Rosen GM, Rauckman EJ. Spin trapping of superoxide and hydroxyl radical: Practical aspects. Arch Biochem Biophys 1980; 200: 1-16.
37. Britigan BE, Rosen GM, Chai Y, Cohen MS. Do human neutrophils make hydroxyl radical?. J Biol Chem 1986; 261: 4426-31.
38. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996; 93: 6770-4.
39. Stringer KA, Branconi JM, Abadier R, Wilton JH, Royal SH. Disposition of oral dipyridamole in patients undergoing thallium 201 myocardial imaging. Pharmacology 1992; 12: 83-7.